1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
Clinical and imaging data in patients with good-versus-poor functional outcome using mRS >2 as a cutoff
VariableOverall (n = 50)Good Outcome (n = 22)Poor Outcome (n = 28)P Value
Age (mean) (SD) (yr)70.0 (13.0)65.1 (12.8)73.8 (12.1).02
Sex (M/F)23:2713:910:18.10
Baseline NIHSS (median) (IQR)15 (11–21)11 (8–14)20 (14–22).001
Time from symptom onset (mean) (SD) (hr)8.4 (5.6)8.8 (6.7)8.1 (4.6).62
Consensus ASPECTS ≥ 6 (No.) (%)4321 (95%)22 (78%).10
Automated ASPECTS ≥ 6 (No.) (%)4521 (95%)24 (85%).26
CTP-CBV ASPECTS ≥ 6 (No.) (%)4321 (95%)22 (78%).10
Final infarction volume (mean) (SD) (mL)4924.4 (29.0)57.5 (64.7).03